Clinical Trial Update: Taxol Carboplatin and Erythropoetin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel (Taxol) with carboplatin and erythropoietin for ovarian cancer; results from the completed study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Epogen (epoetin alfa)
• Taxol (paclitaxel)

Snippet

Sponsor: North Eastern German Society of Gynaecological Oncology | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-11-25